Literature DB >> 19055943

Adhesion proteins meet receptors: a common theme?

Véronique Orian-Rousseau1, Helmut Ponta.   

Abstract

Receptors tyrosine kinases (RTKs) and cell adhesion molecules (CAMs) present on the cell surface sense the surrounding environment and influence the fate of cells. For a long time, it was believed that these molecules were working independently and that the sole binding of a ligand was enough to activate the RTK. It is now apparent that there is, in fact, a very tight connection between RTKs and CAMs and that they work in concert. The CAMs influence the activation, the signaling, or the internalization of the RTKs. Some CAMs have similar functions and are therefore interchangeable. CD44 isoforms exemplify the flexibility of these interactions as they can collaborate with several RTKs and can also be substituted by other CAMs with similar functions. In several instances, CAMs not only control the activation of the receptor by presenting the ligand but also regulate the downstream signaling by organizing a signalosome complex. Furthermore, the functions of the CAMs can be controlled by the cellular environment and the binding to their ligands.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19055943     DOI: 10.1016/S0065-230X(08)00404-1

Source DB:  PubMed          Journal:  Adv Cancer Res        ISSN: 0065-230X            Impact factor:   6.242


  34 in total

1.  Large-scale phosphotyrosine proteomic profiling of rat renal collecting duct epithelium reveals predominance of proteins involved in cell polarity determination.

Authors:  Boyang Zhao; Mark A Knepper; Chung-Lin Chou; Trairak Pisitkun
Journal:  Am J Physiol Cell Physiol       Date:  2011-09-21       Impact factor: 4.249

Review 2.  Single-spanning transmembrane domains in cell growth and cell-cell interactions: More than meets the eye?

Authors:  Pierre Hubert; Paul Sawma; Jean-Pierre Duneau; Jonathan Khao; Jérôme Hénin; Dominique Bagnard; James Sturgis
Journal:  Cell Adh Migr       Date:  2010-04-20       Impact factor: 3.405

Review 3.  Effects of membrane trafficking on signaling by receptor tyrosine kinases.

Authors:  Marta Miaczynska
Journal:  Cold Spring Harb Perspect Biol       Date:  2013-11-01       Impact factor: 10.005

4.  Hyaluronan synthase 2 (HAS2) promotes breast cancer cell invasion by suppression of tissue metalloproteinase inhibitor 1 (TIMP-1).

Authors:  Berit Bernert; Helena Porsch; Paraskevi Heldin
Journal:  J Biol Chem       Date:  2011-10-20       Impact factor: 5.157

5.  CD44v6 dependence of premetastatic niche preparation by exosomes.

Authors:  Thorsten Jung; Donatello Castellana; Pamela Klingbeil; Ines Cuesta Hernández; Mario Vitacolonna; David J Orlicky; Steve R Roffler; Pnina Brodt; Margot Zöller
Journal:  Neoplasia       Date:  2009-10       Impact factor: 5.715

Review 6.  Emerging role for ERM proteins in cell adhesion and migration.

Authors:  Monique Arpin; Dafne Chirivino; Alexandra Naba; Ingrid Zwaenepoel
Journal:  Cell Adh Migr       Date:  2011-03-01       Impact factor: 3.405

Review 7.  Hyaluronan-CD44 interactions as potential targets for cancer therapy.

Authors:  Suniti Misra; Paraskevi Heldin; Vincent C Hascall; Nikos K Karamanos; Spyros S Skandalis; Roger R Markwald; Shibnath Ghatak
Journal:  FEBS J       Date:  2011-03-25       Impact factor: 5.542

8.  The Drosophila Hedgehog receptor component Interference hedgehog (Ihog) mediates cell-cell interactions through trans-homophilic binding.

Authors:  Xuefeng Wu; Ya Zhang; Kun-Han Chuang; Xudong Cai; Humna Ajaz; Xiaoyan Zheng
Journal:  J Biol Chem       Date:  2019-06-17       Impact factor: 5.157

9.  Isoform 5 of PIPKIγ regulates the endosomal trafficking and degradation of E-cadherin.

Authors:  Nicholas J Schill; Andrew C Hedman; Suyong Choi; Richard A Anderson
Journal:  J Cell Sci       Date:  2014-03-07       Impact factor: 5.285

10.  Differential recruitment of CD44 isoforms by ErbB ligands reveals an involvement of CD44 in breast cancer.

Authors:  Iris Morath; Christian Jung; Romain Lévêque; Chen Linfeng; Robert-Alain Toillon; Arne Warth; Véronique Orian-Rousseau
Journal:  Oncogene       Date:  2018-01-11       Impact factor: 9.867

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.